BVF INC Overview
Bvf Inc is a hedge fund that manages 1.2 BN dollars in regulatory AUM and has 7 employees, of which 6 perform investment advisory functions.
The manager's has disclosed holdings from 03/31/01 to 03/31/19. The fund's latest filing disclosed 893MM in positions, representing 72% of the manager's regulatory AUM.
The manager's has disclosed holdings from 03/31/01 to 03/31/19. The fund's latest filing disclosed 893MM in positions, representing 72% of the manager's regulatory AUM.
BVF INC StockAlpha
| Top 25% |
3yr StockAlpha
Register for more...
Fundamental & Technical Factor Exposure
BVF INC Since Last Filing Return Details
| Ticker | Size | Sector | Stock Move | StockAlpha Attribution | Days to Liquidate | Trade Crowdedness | ||
|---|---|---|---|---|---|---|---|---|
| ARRY | 9.34% | Health | -10.58% | -0.6% | 1 | 3% | ||
| MRUS | 7.51% | Health | -2.37% | -0.01% | 37 | 0% | ||
|
Unlock Positions and Returns Details |
||||||||
FEATURED IN
BVF INC Founders and Key Employees
| Name | Title | In Position Since |
|---|
| Mark N. Lampert | Chief Executive Officer | November-1993 |
| Spike N. Loy | Chief Compliance Officer | June-2011 |
| Matthew Perry | President | March-2014 |
BVF INC Brokers, Custodians, Auditors and Administrators
| Type | Company |
|---|
| Administrator | Pro |
| Auditor | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Prime Broker | Pro |
| Prime Broker | Pro |
| Prime Broker | Pro |
BVF INC Investment Strategy
Methods of Analysis, Investment Strategies and Risk of Loss
Methods of Analysis, Investment Strategies
BVF invests primarily in biotechnology companies that possess proprietary drug discovery expertise and core technologies that can be leveraged into a stream of product opportunities. In particular, BVF seeks out biotechnology companies which have established, or are likely to establish, important partnerships with large drug companies. In selecting investments for Clients, BVF focuses on a variety of quantitative and qualitative metrics.
Risk Factors
The investment strategies pursued by BVF are speculative, involve a substantial degree of risk and are not intended as a complete investment program. An investment with BVF is suitable only for financially sophisticated investors who fully understand and are capable of bearing the risk of such an investment, including significant volatility and the loss of all or substantially all of their ...
Unlock Full Investment Process Description
Methods of Analysis, Investment Strategies
BVF invests primarily in biotechnology companies that possess proprietary drug discovery expertise and core technologies that can be leveraged into a stream of product opportunities. In particular, BVF seeks out biotechnology companies which have established, or are likely to establish, important partnerships with large drug companies. In selecting investments for Clients, BVF focuses on a variety of quantitative and qualitative metrics.
Risk Factors
The investment strategies pursued by BVF are speculative, involve a substantial degree of risk and are not intended as a complete investment program. An investment with BVF is suitable only for financially sophisticated investors who fully understand and are capable of bearing the risk of such an investment, including significant volatility and the loss of all or substantially all of their ...
Unlock Full Investment Process Description
BVF INC Portfolio Concentration
BVF INC Location
ONE SANSOME STREET
30TH FLOOR
SAN FRANCISCO, California
UNITED STATES, 94104-4436
30TH FLOOR
SAN FRANCISCO, California
UNITED STATES, 94104-4436
BVF INC Contact Information
Phone Number: 415-525-8890
Fax Number: 415-288-2394
Website: http://www.bvflp.com
Fax Number: 415-288-2394
Website: http://www.bvflp.com
READ RECENT SYMMETRIC REPORTS
Disclaimer
The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here